🟢 Ind-Swift Laboratories is trading 5% up today after shareholder approval of ₹137.20 crore warrants

Ind-Swift Laboratories is trading at INR 240.00, up +5.07%, after shareholder approval of ₹137.20 crore of fully convertible warrants to promoter entities on August 5, 2026.

• Proceeds will support expansion, research, technology upgrades, and subsidiary investment.
• The company is scheduled to consider June-quarter financial results on August 10, 2026, potentially adding investor interest.
• The price rose from INR 219.82 on July 30 to INR 240.00.